Product Information
LITHIUM CARBONATE ER 300 MG TB is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.1959 per EA under NDC 00054002125. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Oct 28, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054002125
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076832FDA Approved
10/28/2004
TE Code
AB
On Market Since
10/28/2004
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE ER 300 MG TB has been published 665 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1959 per EA |
|---|---|
| All-time high | $0.2271 (Nov 13, 2024) |
| All-time low | $0.1260 (Dec 21, 2022) |
| 52-week high | $0.2097 |
| 52-week low | $0.1959 |
| Median price | $0.1631 |
| Average price | $0.1692 |
| Largest weekly change | +33.8% (Jun 19, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE ER 300 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE ER 300 MG TB, manufactured by Hikma Pharmaceuticals USA Inc., is $0.1959 per EA (NDC 00054002125), effective Aug 19, 2026.
How has the price of LITHIUM CARBONATE ER 300 MG TB changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE ER 300 MG TB has held within roughly two percent of its current level. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE ER 300 MG TB?
Since Nov 28, 2013, the NADAC for LITHIUM CARBONATE ER 300 MG TB has ranged from a low of $0.1260 (Dec 21, 2022) to a high of $0.2271 (Nov 13, 2024), with a median of $0.1631 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE ER 300 MG TB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LITHIUM CARBONATE 300 MG TAB, is $0.1934 per EA — about 1% below LITHIUM CARBONATE ER 300 MG TB.
Who manufactures LITHIUM CARBONATE ER 300 MG TB?
LITHIUM CARBONATE ER 300 MG TB (NDC 00054002125) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.